Cargando…

Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images

BACKGROUND: Distinguishing parotid pleomorphic adenoma (PPA) from parotid adenolymphoma (PA) is important for precision treatment, but there is a lack of readily available diagnostic methods. In this study, we aimed to explore the diagnostic value of radiomic signatures based on magnetic resonance i...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Le-le, Chen, Shun-jun, Chen, Wang, Shi, Zhan, Wang, Xiao-dong, Song, Li-na, Chen, Dian-sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981906/
https://www.ncbi.nlm.nih.gov/pubmed/33743615
http://dx.doi.org/10.1186/s12880-021-00581-9
_version_ 1783667609380585472
author Song, Le-le
Chen, Shun-jun
Chen, Wang
Shi, Zhan
Wang, Xiao-dong
Song, Li-na
Chen, Dian-sen
author_facet Song, Le-le
Chen, Shun-jun
Chen, Wang
Shi, Zhan
Wang, Xiao-dong
Song, Li-na
Chen, Dian-sen
author_sort Song, Le-le
collection PubMed
description BACKGROUND: Distinguishing parotid pleomorphic adenoma (PPA) from parotid adenolymphoma (PA) is important for precision treatment, but there is a lack of readily available diagnostic methods. In this study, we aimed to explore the diagnostic value of radiomic signatures based on magnetic resonance imaging (MRI) for PPA and PA. METHODS: The clinical characteristic and imaging data were retrospectively collected from 252 cases (126 cases in the training cohort and 76 patients in the validation cohort) in this study. Radiomic features were extracted from MRI scans, including T1-weighted imaging (T1WI) sequences and T2-weighted imaging (T2WI) sequences. The radiomic features from three sequences (T1WI, T2WI and T1WI combined with T2WI) were selected using univariate analysis, LASSO correlation and Spearman correlation. Then, we built six quantitative radiomic models using the selected features through two machine learning methods (multivariable logistic regression, MLR, and support vector machine, SVM). The performances of the six radiomic models were assessed and the diagnostic efficacies of the ideal T1-2WI radiomic model and the clinical model were compared. RESULTS: The T1-2WI radiomic model using MLR showed optimal discriminatory ability (accuracy = 0.87 and 0.86, F-1 score = 0.88 and 0.86, sensitivity = 0.90 and 0.88, specificity = 0.82 and 0.80, positive predictive value = 0.86 and 0.84, negative predictive value = 0.86 and 0.84 in the training and validation cohorts, respectively) and its calibration was observed to be good (p > 0.05). The area under the curve (AUC) of the T1-2WI radiomic model was significantly better than that of the clinical model for both the training (0.95 vs. 0.67, p < 0.001) and validation (0.90 vs. 0.68, p = 0.001) cohorts. CONCLUSIONS: The T1-2WI radiomic model in our study is complementary to the current knowledge of differential diagnosis for PPA and PA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12880-021-00581-9.
format Online
Article
Text
id pubmed-7981906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79819062021-03-22 Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images Song, Le-le Chen, Shun-jun Chen, Wang Shi, Zhan Wang, Xiao-dong Song, Li-na Chen, Dian-sen BMC Med Imaging Research Article BACKGROUND: Distinguishing parotid pleomorphic adenoma (PPA) from parotid adenolymphoma (PA) is important for precision treatment, but there is a lack of readily available diagnostic methods. In this study, we aimed to explore the diagnostic value of radiomic signatures based on magnetic resonance imaging (MRI) for PPA and PA. METHODS: The clinical characteristic and imaging data were retrospectively collected from 252 cases (126 cases in the training cohort and 76 patients in the validation cohort) in this study. Radiomic features were extracted from MRI scans, including T1-weighted imaging (T1WI) sequences and T2-weighted imaging (T2WI) sequences. The radiomic features from three sequences (T1WI, T2WI and T1WI combined with T2WI) were selected using univariate analysis, LASSO correlation and Spearman correlation. Then, we built six quantitative radiomic models using the selected features through two machine learning methods (multivariable logistic regression, MLR, and support vector machine, SVM). The performances of the six radiomic models were assessed and the diagnostic efficacies of the ideal T1-2WI radiomic model and the clinical model were compared. RESULTS: The T1-2WI radiomic model using MLR showed optimal discriminatory ability (accuracy = 0.87 and 0.86, F-1 score = 0.88 and 0.86, sensitivity = 0.90 and 0.88, specificity = 0.82 and 0.80, positive predictive value = 0.86 and 0.84, negative predictive value = 0.86 and 0.84 in the training and validation cohorts, respectively) and its calibration was observed to be good (p > 0.05). The area under the curve (AUC) of the T1-2WI radiomic model was significantly better than that of the clinical model for both the training (0.95 vs. 0.67, p < 0.001) and validation (0.90 vs. 0.68, p = 0.001) cohorts. CONCLUSIONS: The T1-2WI radiomic model in our study is complementary to the current knowledge of differential diagnosis for PPA and PA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12880-021-00581-9. BioMed Central 2021-03-20 /pmc/articles/PMC7981906/ /pubmed/33743615 http://dx.doi.org/10.1186/s12880-021-00581-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Song, Le-le
Chen, Shun-jun
Chen, Wang
Shi, Zhan
Wang, Xiao-dong
Song, Li-na
Chen, Dian-sen
Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images
title Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images
title_full Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images
title_fullStr Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images
title_full_unstemmed Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images
title_short Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images
title_sort radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on mri images
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981906/
https://www.ncbi.nlm.nih.gov/pubmed/33743615
http://dx.doi.org/10.1186/s12880-021-00581-9
work_keys_str_mv AT songlele radiomicmodelfordifferentiatingparotidpleomorphicadenomafromparotidadenolymphomabasedonmriimages
AT chenshunjun radiomicmodelfordifferentiatingparotidpleomorphicadenomafromparotidadenolymphomabasedonmriimages
AT chenwang radiomicmodelfordifferentiatingparotidpleomorphicadenomafromparotidadenolymphomabasedonmriimages
AT shizhan radiomicmodelfordifferentiatingparotidpleomorphicadenomafromparotidadenolymphomabasedonmriimages
AT wangxiaodong radiomicmodelfordifferentiatingparotidpleomorphicadenomafromparotidadenolymphomabasedonmriimages
AT songlina radiomicmodelfordifferentiatingparotidpleomorphicadenomafromparotidadenolymphomabasedonmriimages
AT chendiansen radiomicmodelfordifferentiatingparotidpleomorphicadenomafromparotidadenolymphomabasedonmriimages